Literature DB >> 17706603

Ginger ingredients reduce viability of gastric cancer cells via distinct mechanisms.

Kazuhiro Ishiguro1, Takafumi Ando2, Osamu Maeda2, Naoki Ohmiya2, Yasumasa Niwa2, Kenji Kadomatsu3, Hidemi Goto2.   

Abstract

Ginger has been used throughout the world as spice, food and traditional herb. We found that 6-gingerol, a phenolic alkanone isolated from ginger, enhanced the TRAIL-induced viability reduction of gastric cancer cells while 6-gingerol alone affected viability only slightly. 6-Gingerol facilitated TRAIL-induced apoptosis by increasing TRAIL-induced caspase-3/7 activation. 6-Gingerol was shown to down-regulate the expression of cIAP1, which suppresses caspase-3/7 activity, by inhibiting TRAIL-induced NF-kappaB activation. As 6-shogaol has a chemical structure similar to 6-gingerol, we also assessed the effect of 6-shogaol on the viability of gastric cancer cells. Unlike 6-gingerol, 6-shogaol alone reduced the viability of gastric cancer cells. 6-Shogaol was shown to damage microtubules and induce mitotic arrest. These findings indicate for the first time that in gastric cancer cells, 6-gingerol enhances TRAIL-induced viability reduction by inhibiting TRAIL-induced NF-kappaB activation while 6-shogaol alone reduces viability by damaging microtubules.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706603     DOI: 10.1016/j.bbrc.2007.08.012

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  In-vitro antimicrobial activity and identification of bioactive components using GC-MS of commercially available essential oils in Saudi Arabia.

Authors:  Syed Amir Ashraf; Eyad Al-Shammari; Talib Hussain; Shaikh Tajuddin; Bibhu Prasad Panda
Journal:  J Food Sci Technol       Date:  2017-09-21       Impact factor: 2.701

2.  Bortezomib synergizes TRAIL-induced apoptosis in gastric cancer cells.

Authors:  Jing Liu; Xiu-Juan Qu; Ling Xu; Ye Zang; Jing-Lei Qu; Ke-Zuo Hou; Yun-Peng Liu
Journal:  Dig Dis Sci       Date:  2010-12       Impact factor: 3.199

Review 3.  Non-pharmacological treatment of Helicobacter pylori.

Authors:  Haim Shmuely; Noam Domniz; Jacob Yahav
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

4.  Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects.

Authors:  Suzanna M Zick; Zora Djuric; Mack T Ruffin; Amie J Litzinger; Daniel P Normolle; Sara Alrawi; Meihua Rose Feng; Dean E Brenner
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

5.  Pungent ginger components modulates human cytochrome P450 enzymes in vitro.

Authors:  Mian Li; Pei-zhan Chen; Qing-xi Yue; Jing-quan Li; Rui-ai Chu; Wei Zhang; Hui Wang
Journal:  Acta Pharmacol Sin       Date:  2013-06-17       Impact factor: 6.150

6.  Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4/NF-κB signaling by 6-shogaol.

Authors:  Ling Zhou; Lianwen Qi; Lifeng Jiang; Ping Zhou; Jiang Ma; Xiaojun Xu; Ping Li
Journal:  AAPS J       Date:  2014-01-15       Impact factor: 4.009

7.  Gingerol sensitizes TRAIL-induced apoptotic cell death of glioblastoma cells.

Authors:  Dae-Hee Lee; Dong-Wook Kim; Chang-Hwa Jung; Yong J Lee; Daeho Park
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-14       Impact factor: 4.219

Review 8.  Next-Gen Therapeutics for Skin Cancer: Nutraceuticals.

Authors:  Annapoorna Sreedhar; Jun Li; Yunfeng Zhao
Journal:  Nutr Cancer       Date:  2018-05-15       Impact factor: 2.900

9.  Comprehensive evaluation of a novel nuclear factor-kappaB inhibitor, quinoclamine, by transcriptomic analysis.

Authors:  W-Y Cheng; J-C Lien; C-Y Hsiang; S-L Wu; C-C Li; H-Y Lo; J-C Chen; S-Y Chiang; J-A Liang; T-Y Ho
Journal:  Br J Pharmacol       Date:  2009-04-30       Impact factor: 8.739

Review 10.  Phytoconstituents as apoptosis inducing agents: strategy to combat cancer.

Authors:  Manish Kumar; Varinder Kaur; Subodh Kumar; Satwinderjeet Kaur
Journal:  Cytotechnology       Date:  2015-08-04       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.